
Please try another search
Today's IPO for OKYO Pharma Limited (Nasdaq: OKYO) opened for trading at $4.50 per ADS after pricing 625,000 ADSs (representing 40,625,000 new ordinary shares of no par value) at a price of $4.00 per ADS.
ThinkEquity LLC was the sole bookrunning manager for the IPO.
OKYO Pharma is a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain.
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Thursday, June 30th. Please refresh for updates. Walgreens Boots (NASDAQ:WBA) stock fell 1.9% after the...
Northland Capital Markets analyst Gus Richard upgraded shares of AMD (AMD) to Outperform from Market Perform with a price target cut to $95.00 per share. The analyst believes macro...
(Bloomberg) -- China is the best place to buy tech stocks as valuations in the US remain too high to be attractive, according to Invesco Ltd. Beijing’s crackdown on everything --...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.